Elbit reports lower ultrasound sales

Article

Elbit Medical Imaging of Haifa, Israel, reported that sales in its Elbit Ultrasound unit were $182.4 million for its 1997 fiscal year (end-December), down 13% compared with revenues of $208.9 million in 1996. For the fourth quarter, the division had

Elbit Medical Imaging of Haifa, Israel, reported that sales in its Elbit Ultrasound unit were $182.4 million for its 1997 fiscal year (end-December), down 13% compared with revenues of $208.9 million in 1996. For the fourth quarter, the division had revenues of $58.6 million, compared with $63.6 million in the fourth quarter of 1996, a decline of 8%.

Elbit said the reduction in the ultrasound division's revenues was primarily due to the discontinuation of sales of Hitachi Ultrasound products, which Elbit Ultrasound distributed until December 1996. Sales of Hitachi products contributed $32 million to Elbit Ultrasound's revenues in 1996.

The ultrasound division is composed of Diasonics Vingmed Ultrasound, which Elbit has agreed to sell to GE Medical Systems (SCAN 3/4/98). Elbit said it continues to work on GE's proposal to acquire Diasonics Vingmed, and hopes to have a final agreement signed by the end of March.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.